Canine transmissible venereal tumor with spontaneous remission: case study with emphasis on clinical and cytopathological exams to monitor tumor evolution
DOI:
https://doi.org/10.1590/1809-6891v23e-72748EAbstract
The canine transmissible venereal tumor (TVTC) is a neoplasm transmitted mainly through copulation and with a high incidence in stray dogs in Brazil. In the process of tumor evolution of TVTC, the progression, stationary and regression phases are recognized. The host immunity is related to the disease’s biological behavior, however, spontaneous regression observation in cases of naturally occurring TVTC is uncommon. A canine patient was attended, after beeing rescued from the street, due to an ulcerated mass in the external genitália and tick infestation. Cytopathological examination, which diagnosed TVTC, and laboratory tests that showed mild anemia and severe thrombocytopenia were performed. In view of the impossibility of carrying out other exams, it was made the presumptive diagnosis of canine monocytic ehrlichiosis (CME), and treatment was instituted. During follow-up it was observed quick improvement in clinical signs and laboratory changes, as well as a reduction in tumor mass. A new cytopathological evaluation was carried out, and was verified increase in mature lymphocytes and plasmocytes in the midst of the tumor cells, finding compatible with the stationary phase of the disease. From that moment on, it was decided to perform only clinical and cytopathological follow-up. In the following evaluations, continuous clinical remission and cytopathological findings compatible with those described in the regression phase were observed, until its complete remission. It is considered that the improvement in the general health of the patient after the treatment of CME is related to the spontaneous regression of TVTC, and that simultaneous performance of serial clinical and cytopathological exams may be feasible and useful for monitoring the stages of evolution of TVTC.
Keywords: cytopatology; dogs; erlichiosis; neoplasia; round cell.
Downloads
References
Murchison EP, Wedge DC, Alexandrov LB, Fu B, Martincorena I, Ning Z, Tubio JMC, Werner EI, Allen J, De Nardi AB, Donelan EM, Marino G, Fassati A, Campbell PJ, Yang F, Burt A, Weiss RA, Stratton MR. Transmissible dog cancer genome reveals the origin and history of an ancient cell lineage. Science. 2014;343(6169):437-440. doi: 10.1126/science.1247167
Abeka YT. Review on Canine Transmissible Venereal Tumor (CTVT). Cancer Therapy and Oncology International Journal. 2019;14(4):1-9. doi: 10.19080/CTOIJ.2019.14.555895
Woods JP. Canine Transmissible Venereal Tumor. In: Vail D, Thamm DH, Liptak JM. Withrow & MacEwen’s Small Animal Clinical Oncology. 6 ed. St. Louis, Missouri: Elsevier; 2020. p.781-784.
Ostrander A, Davis BW, Ostrander GK. Transmissible tumors: Breaking the Cancer Paradigm. Trends in Genetics. 2016;32(1):1-15. doi: 10.1016/j.tig.2015.10.001
Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT? Research in Veterinary Science. 2022;145:193-204. doi: https://doi.org/10.1016/j.rvsc.2022.02.020
Ujvari B, Gatenby RA, Thomas F. The evolutionary ecology of transmissible cancers. Infection, Genetics and Evolution. 2016;39:293-303. doi: 10.1016/j.meegid.2016.02.005
Ganguly B, Das U, Das AK. Canine Transmissible Venereal Tumour: a Review. Veterinary Comparative Oncology. 2013;14(1):1-12. doi: 10.1111/vco.12060
Hsiao Y, Liao KW, Hung SW, Chu RM. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-β1 and restores the lymphokine-activated killing activity. The Journal of Immunology. 2014;172(3):1508-1514. doi: 10.4049/jimmunol.172.3.1508
Liu CC, Wang YS, Lin CY, Chuang TF, Liao KW, Chi KH, Chen MF, Chiang HC, Chu RM. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor. Cancer Immunology, Immunotherapy. 2008;57(4):479-491. doi: 10.1007/s00262-007-0386-0
Siddle HV, Kaufman J. Immunology of naturally transmissible tumours. Immunology. 2015;144(1):11-20. doi: 10.1111/imm.12377
Costa TS, Paiva FN, Gonzaga GM, Berutti BM, Veiga CCP, Spíndola BF, Alonso LS, Fernandes JI. Canine Transmissible Venereal Tumor in the Larynx with Pulmonary Metastasis. Acta Scientiae Veterinariae. 2022; 50(Suppl 1): 764. doi: 10.22456/1679-9216.120292.
Costa MT, Castro KF. Tumor venéreo transmissível. In: Daleck CR, De Nardi AB. Oncologia em cães e gatos. 2 ed. São Paulo: Editora Roca; 2016. p. 991-1013.
Hsiao YW, Liao KW, Chung TF, Liu CH, Hsu CD, Chu RM. Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression. Cancer Immunology, Immunotherapy. 2008;57(7):1091-1104. doi: 10.1007/s00262-007-0446-5
Agnew DW, Maclachlan NJ. Tumors of genital system. In: Meuten DJ. Tumors in domestic animals. 5 ed. Ames: Willey Blackwell; 2017. p.689-722.
Ballestero FH, Montoya FL, Yamatogi RS, Duzanski AP, Araújo JP, Oliveira RA, Rocha NS. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs? Veterinary and Comparative Oncology. 2018;16(3):370-378. doi: 10.1111/vco.12388
Amaral AS, Silva SB, Ferreira I, Fonseca LS, Andrade FHEA, Gaspar LFJ, Rocha NS. Cytomorphological characterization of transmissible canine venereal tumor. Revista Portuguesa de ciências veterinárias. 2007;102(563-564):253-260. Disponivel em: http://www.fmv.ulisboa.pt/spcv/12_2007.htm
Lima CRO, Rabelo RE, Vulcani VAS, Furtado AP, Helrigel PA, Brito LAB, Moura VMBD. Morphological patterns and malignancy criteria of transmissible venereal tumor in cytopathological and histopathological exams. Brazilian Journal of Veterinary Research and Animal Science. 2013;50(3):238-246. doi: https://doi.org/10.11606/issn.1678-4456.v50i3p238-246
Pimentel PA, Oliveira CS, Horta RS. Epidemiological study of canine transmissible venereal tumor (CTVT) in Brazil, 2000–2020. Preventive veterinary medicine. 2021;197:105526. doi: https://doi.org/10.1016/j.prevetmed.2021.105526.
Huppes RR, Silva CG, Uscategui RAR, De Nardi AB, Souza FW, Tinucci-Costa M, Amorim RL, Pazzini JM, Faria JML. Venereal Transmissible Tumor (TVT): Retrospective Study of 144 Cases. Ars Veterinaria. 2014;30(1):13-18. doi: http://dx.doi.org/10.15361/2175-0106.2014v30n1p13-18
Strakova A, Murchison EP. The changing global distribution and prevalence of canine transmissible venereal tumour. BMC veterinary research. 2014;10(1):1-11. doi: https://doi.org/10.1186/s12917-014-0168-9
Solano-Gallego L, Miró G, Koutinas A, Cardoso L, Pennisi MG, Ferrer L, Bourdeau P, Oliva G, Baneth G. LeishVet guidelines for the practical management of canine leishmaniosis. Parasites & vectors. 2011;4(1):1-16. doi: https://doi.org/10.1186/1756-3305-4-86
Sainz A, Roura X, Miró G, Estrada-Peña A, Kohn B, Harrus S, Solano-Gallego L. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. Parasites & vectors. 2015;8(1):1-20. doi: https://doi.org/10.1186/s13071-015-0649-0
Birhan G, Chanie M. A review on canine transmissible venereal tumor: from morphologic to biochemical and molecular diagnosis. Academic Journal of Animal Diseases. 2015;4(3):185-195. doi: 10.5829/idosi.ajad.2015.4.3.95245
Silva MVM, Fernandes RA, Nogueira JL, Ambrósio CE. Erliquiose canina: revisão de literatura. Arquivos de Ciências Veterinárias e Zoologia da UNIPAR. 2011;14(2):139-143. Disponivel em: https://revistas.unipar.br/index.php/veterinaria/article/view/4149
Sousa VRF, Almeida ABPF, Barros LA, Sales KG, Justino CHS, Dalcin L, Bomfim TCB. Avaliação clínica e molecular de cães com erliquiose. Ciência Rural. 2010;40(6):1309-1313. doi: https://doi.org/10.1590/S0103-84782010000600011
Das Neves EC, De Souza SF, De Carvalho YK, Ribeiro VMF, Medeiros LS. Erliquiose Monocítica Canina: Uma zoonose em ascensão e suas limitações diagnósticas no Brasil. Medvep - Revista Científica de Medicina Veterinária - Pequenos Animais e Animais de Estimação. 2014;12(40):1-7. Disponível em: https://medvep.com.br/erliquiose-monocitica-canina-uma-zoonose-em-ascensao-e-suas-limitacoes-diagnosticas-no-brasil/
Arcila-Villa A, Dussán-Lubert C, Pedraza-Ordoñez F. Distribution and prevalence of transmissible venereal tumor in the Colombian canine population. Revista Colombiana de Ciencias Pecuarias. 2018;31(3):180-187. doi: 10.17533/udea.rccp.v31n3a02
Frampton D, Schwenzer H, Marino G, Butcher LM, Pollara G, Kriston-Vizi J, Venturini C, Austin R, De Castro KF, Ketteler R, Chain B, Goldstein RA, Weiss RA, Beck S, Fassati A. Molecular signatures of regression of the canine transmissible venereal tumor. Cancer Cell. 2018;33:620-633. doi: 10.1016/j.ccell.2018.03.003.
Alzate JM, Montoya-Florez LM, Pérez JE, Rocha NS, Pedraza-Ordonez FJ. The role of the multi‐drug resistance 1, p53, b cell lymphoma 2, and bcl 2‐associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors. Veterinary clinical pathology. 2019;48(4):730-739. doi: 10.1111/vcp.12805.
Stockmann D, Ferrari HF, Andrade AL, Lopes RA, Cardoso TC, Luvizotto MCR. Canine transmissible venereal tumors: aspects related to programmed cell death. Brazilian Journal of Veterinary Pathology. 2011;4(1):67-75. Disponível em: http://hdl.handle.net/11449/72386
Santos FGA, Vasconcelos AC, Nunes JES, Cassali GD, Paixão TA, Martins AS, Silva SS, Martins RF, Moro L. Apoptosis in the transplanted canine transmissible venereal tumor during growth and regression phases. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 2008;60(3):607-612. doi: https://doi.org/10.1590/S0102-09352008000300013
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Brazilian Animal Science/ Ciência Animal Brasileira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
